Directorio

Es posible que algunos contenidos no estén disponibles en español.
433 clinical trials found.
Skin, Hair and Nails

We are doing this study to find out if an experimental drug called IMVT-1402 (the study drug) can help control cutaneous lupus erythematosus (CLE). We want to know how well the study drug works in comparison to a placebo (inactive substance that has no drug in it).

Compensation: Yes
Ages: 18-110
Non-Oncology
Other
Thoracic Cancer

We are doing this study to compare 2 different approaches for patients who have surgery to remove non-small cell lung cancer (NSCLC). We want to see if giving patients an immunotherapy drug called durvalumab (the study drug) after surgery has different outcomes than the usual approach, which is to closely monitor a patient's condition for any changes.

Compensation: No
Ages: 18-110
Oncology
Duke University Hospital, Duke Raleigh Hospital
Eyes and Vision

We are doing this study to find out if images taken of the eye using a special type of camera placed inside a surgical microscope, called Microscope Integrated Optical Coherence Tomography (MIOCT), will give us new information during surgery that will improve both how we perform eye surgery and the results of surgery.

Compensation: No
Ages: 0-110
Non-Oncology
Duke University Hospital
Surgery and Rehabilitation

We are doing this study to find out if an experimental drug called ASP5354 (the study drug) is a safe and effective option that can help surgeons see patients' ureters better during surgeries.

Compensation: No
Ages: 18-110
Non-Oncology
Duke University Hospital
Heart and Circulation

We are using this registry to learn more about acute aortic dissection from hospitals across the country.

Compensation: No
Non-Oncology
Genitourinary Cancer

We are doing this study to learn more about prostate cancer and whether certain treatments are related with different outcomes and patient experiences.

Compensation: No
Oncology
Men's Health

We are doing this study to learn more about the impact that penile prosthesis devices have on the quality of life with men who have ED.

Compensation: Yes
Ages: 18-110
Non-Oncology
Duke Raleigh Hospital
Brain and Spine Metastasis

We are doing this study to find out if an experimental drug combination made up of ivosidenib, gemcitabine, cisplatin, and durvalumab is a safe and effective for treating cholangiocarcinoma.

Compensation: No
Ages: 18-110
Oncology
Duke University Hospital